MAC LUNG DISEASE
Clinical trials for MAC LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new MAC LUNG DISEASE trials appear
Sign up with your email to follow new studies for MAC LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stubborn lung infection: experimental pill shows promise
Disease control TerminatedThis study tested an experimental oral drug called epetraborole for people with a hard-to-treat lung infection caused by MAC bacteria. The trial was for adults whose infection did not get better with standard treatments. The study was stopped early, so final results are not avail…
Matched conditions: MAC LUNG DISEASE
Phase: PHASE2, PHASE3 • Sponsor: AN2 Therapeutics, Inc • Aim: Disease control
Last updated Jun 17, 2026 05:43 UTC
-
New inhaled therapy for stubborn lung infection shows promise in Late-Stage trial
Disease control TerminatedThis study tested an inhaled form of the drug clofazimine in people with a stubborn lung infection called MAC (nontuberculous mycobacteria) that did not get better with standard treatment. The goal was to see if adding this inhaled drug to usual care could clear the infection fro…
Matched conditions: MAC LUNG DISEASE
Phase: PHASE3 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jun 17, 2026 05:43 UTC